News
ITGR
140.62
+0.70%
0.98
Integer Holdings Is Maintained at Neutral by Citigroup
Dow Jones · 15h ago
Integer Holdings Price Target Raised to $145.00/Share From $130.00 by Citigroup
Dow Jones · 15h ago
Citigroup Maintains Neutral on Integer Holdings, Raises Price Target to $145
Benzinga · 16h ago
Integer Holdings Is Maintained at Buy by Truist Securities
Dow Jones · 21h ago
Integer Holdings Price Target Raised to $163.00/Share From $147.00 by Truist Securities
Dow Jones · 21h ago
Truist Securities Maintains Buy on Integer Holdings, Raises Price Target to $163
Benzinga · 21h ago
Integer price target raised to $163 from $147 at Truist
TipRanks · 22h ago
Truist Financial Remains a Buy on Integer Holdings (ITGR)
TipRanks · 22h ago
Integer price target raised to $145 from $130 at Citi
TipRanks · 23h ago
Weekly Report: what happened at ITGR last week (1202-1206)?
Weekly Report · 3d ago
Returns On Capital At Integer Holdings (NYSE:ITGR) Have Hit The Brakes
Simply Wall St · 12/04 15:23
Integer Holdings Reaches Analyst Target Price
NASDAQ · 12/04 11:55
Decoding 11 Analyst Evaluations For Integer Holdings
Benzinga · 12/03 12:01
Integer Holdings Price Target Announced at $160.00/Share by Wells Fargo
Dow Jones · 12/03 11:46
Wells Fargo Reinstates Overweight on Integer Holdings, Announces $160 Price Target
Benzinga · 12/03 11:36
Buy Rating for Integer Holdings (ITGR) Driven by Strong Growth Potential and Strategic Positioning
TipRanks · 12/03 10:46
Weekly Report: what happened at ITGR last week (1125-1129)?
Weekly Report · 12/02 09:08
Weekly Report: what happened at ITGR last week (1118-1122)?
Weekly Report · 11/25 09:08
Franklin Small Cap Growth Fund Q3 2024 Commentary
Seeking Alpha · 11/22 15:20
Integer Holdings Insiders Sold US$3.5m Of Shares Suggesting Hesitancy
Simply Wall St · 11/21 10:43
More
Webull provides a variety of real-time ITGR stock news. You can receive the latest news about Integer Hldgs Corp through multiple platforms. This information may help you make smarter investment decisions.
About ITGR
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. It operates through Medical segment, which includes the cardio and vascular; cardiac rhythm management and neuromodulation, and advanced surgical; orthopedics and portable medical product lines. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease.